Table 1.
Summary of approved indications

Abbreviations: AML, acute myeloid leukemia; CMML, chronic myelomonocytic leukemia; EMA, European Medicines Agency; FAB, French-American-British; FDA, U.S. Food and Drug Administration; IPSS, International Prognostic Scoring System; MDS, myelodysplastic syndrome.